TIDMBRSA
BLACKROCK SUSTAINABLE AMERICAN INCOME TRUST PLC
LEI: 549300WWOCXSC241W468 - Article 5 Transparency Directive, DTR 4.2
Half Yearly Financial Report 30 April 2022
Performance record
As at As at
30 April 31 October
2022 2021
Net assets (£'000)1 172,021 165,334
Net asset value per ordinary share (pence) 214.41 206.08
Ordinary share price (mid-market) (pence) 210.00 198.25
Discount to cum income net asset value2 2.1% 3.8%
Russell 1000 Value Index 1728.34 1647.89
--------------- ---------------
Performance (with dividends reinvested)
Net asset value per share2 6.0% 36.0%
Ordinary share price2 8.0% 42.4%
Russell 1000 Value Index 4.9% 35.6%
========= =========
For the six For the six
months ended months ended
30 April 30 April Change
2022 2021 %
Revenue
Net profit on ordinary activities after taxation (£'000) 1,463 2,042 -28.4
Revenue earnings per ordinary share (pence)3 1.82 2.56 -28.9
--------------- --------------- ---------------
Dividends per ordinary share (pence)
1st interim 2.00 2.00 -
2nd interim 2.00 2.00 -
--------------- --------------- ---------------
Total dividends paid/payable 4.00 4.00 -
========= ========= =========
1 The change in net assets reflects market movements and dividends paid
during the period.
2 Alternative Performance Measures, see Glossary in the half yearly report
and financial statements.
3 Further details are given in the Glossary in the half yearly report and
financial statements.
Chairman's Statement
A new investment approach and performance
These are the first set of half yearly results that fully reflect the Company's
new sustainable approach, first adopted on 29 July 2021. While we are only
just under a year in, we are encouraged by the performance of the Company since
the change. We have been able to adhere the fundamental tenets of the Company -
to provide an attractive level of income together with capital appreciation
over the long term - but in a manner consistent with the principles of
sustainable investing.
The Company has also benefited from a shift in the market, away from growth
stocks and in favour of value stocks. These combined have helped deliver strong
relative performance over the six months to 30 April 2022. Amid some turbulent
market conditions, the Company's net asset value per share (NAV) returned 6.0%
compared with a return of 4.9% in the Russell 1000 Value Index. The Company's
share price returned 8.0% over the same period (all figures are in British
Pound Sterling terms with dividends reinvested). Further information on
investment performance is given in the Investment Manager's Report.
Since the period end and up to close of business on 27 June 2022, the Company's
NAV has decreased by 3.1% and the share price has fallen by 6.9% (both
percentages in British Pound Sterling with dividends reinvested).
Market overview
Overall, 2021 was a positive year for the U.S. stock market with a solid
recovery from the broader economy. Steady upward earnings revisions from the
corporate sector supported market gains, while the Federal Reserve kept
interest rates near zero and continued its asset purchase plan, thereby adding
liquidity into markets.
However, the skies darkened at the start of 2022. Although the year started
with great promise, ultimately, rising interest rates, higher inflation and a
slowing economy have led to increased uncertainty. The Russian-Ukraine war
combined with renewed lockdowns in China (to combat COVID-19 outbreaks) dented
global growth expectations. This has been a source of significant volatility in
financial markets. Both bond and equity markets have struggled in the early
months of the year.
Earnings and dividends
The Company's earnings per share for the six months ended 30 April 2022 were
1.82p compared with 2.56p for the corresponding period in 2021. The changes to
the investment mandate and our decision to stop writing covered call options
have impacted the Company's underlying income level. On 22 March 2022, the
Board declared the first quarterly dividend of 2.00p per share which was paid
on 29 April 2022. A second quarterly dividend of 2.00p per share has been
declared and will be paid on 1 July 2022 to shareholders on the register on 20
May 2022. These are in line with payments made in prior years.
BlackRock, our Manager, pays particular attention to the prospective earnings
and dividends from our portfolio companies. The Company continues to retain a
bias to high yielding stocks. It has been a more fertile period for income
seekers with many companies resuming or increasing dividend payouts with the
uncertainty of the pandemic behind them.
Ongoing charges
Following the change in investment mandate, management fees were lowered from
0.75% to 0.70% of the Company's net assets, effective from 30 July 2021. The
ongoing charges for the year ended 31 October 2021 were 1.06% of net assets and
these are expected to fall below 1.0% for the current year.
Shares and shareholders
There is a gradual but noticeable change in our shareholder base in favour of
retail investors, often via share-dealing platforms and away from wealth
managers, which nevertheless still represent the largest body of shareholders.
This trend is common throughout the investment trust world and, unsurprisingly,
it presents both opportunities and challenges. We are exploring new ways to
engage with investors and looking at how to best communicate with them.
Approximately 61% of our share register is owned by wealth managers and 25% by
retail investors.
Share issues and buybacks
During the six months to 30 April 2022, the Company's share price to NAV ranged
between a discount of 0.5% and 8.9%. During the period and up to the date of
this report, no ordinary shares have been reissued or bought back. The Board
will continue to use its authorities to issue and buy back shares when it
considers it in shareholders' interests to do so.
Board changes
Following the retirement of Andrew Irvine, we are delighted to welcome David
Barron to the Board. David was appointed on 22 March 2022 and brings a wealth
of experience, having spent 25 years working in the investment management
sector and was until November 2019 chief executive of Miton Group PLC. Prior to
this he was head of investment trusts at J.P. Morgan Asset Management and,
until 2014, a director of The Association of Investment Companies. He is
currently chairman of Dunedin Income Growth Investment Trust PLC, a
non-executive director of Fidelity Japan Trust PLC and a non-executive Director
of Premier Miton Group PLC.
As mentioned in the Annual Report, I will be retiring at the end of the
Company's financial year on 31 October and I am delighted that Alice Ryder will
succeed me as Chairman. It has been an honour and privilege to be Chairman of
your Company. I would like to thank my Board and management colleagues who have
provided unstinting support throughout my tenure and I wish them well for the
future.
Outlook
The global economy had been in the middle of an uneven recovery from the
COVID-19 pandemic, but the Russia-Ukraine war has cast a shadow over the
longer-term outlook. There are many variables today and this is creating
volatility in financial markets. The immediate threat comes from higher energy
prices, rising food prices and disrupted supply chains, which has left
households and businesses under strain, but there are also longer-term
pressures.
The conflict has changed the outlook for inflation, which remains the key risk
to the market cycle in 2022. The Federal Reserve is currently on a path to
increase interest rates to levels that could clearly slow the economy and
create a worsening environment for the rest of the year and into 2023. However,
the U.S. should be among the more resilient economies globally, given its
energy independence.
This new environment of elevated volatility has crucial implications for stock
selection. The Company's portfolio is weighted towards higher-quality
companies, which should be in a better position to weather higher inflation and
tighter monetary conditions. We believe this environment is likely to favour
value and dividend stocks, as investors increasingly prioritise predictable,
stable cash flows. The Company is well positioned to take advantage of the
investment opportunities ahead, despite the market disruption.
Simon Miller
29 June 2022
Investment Manager's Report
Market overview
For the six-month period ended 30 April 2022, the Company returned 6.0% and
8.0% on a net asset value and share price basis, respectively. This compares to
a 4.9% return for the reference index, the Russell 1000 Value Index. In the
same period, U.S. large cap stocks, as represented by the S&P 500 Index,
declined by 9.6% in US Dollar terms. In British Pound Sterling terms, U.S.
stocks depreciated by 1.4% for the performance period (unless otherwise stated,
all percentages in British Pound Sterling terms with dividends reinvested). We
highlight below some of the key market events during the semi-annual period.
U.S. large-cap stocks rallied during the rest of the third quarter of 2021
driven primarily by better-than-expected corporate earnings results. This trend
continued into the fourth quarter, even as the Federal Reserve's (the Fed) plan
to begin tapering was announced and the Omicron variant began to spread. By
late December, concerns regarding the COVID-19 variant dissipated, due in part
to studies that suggested the variant was less severe than past strains. Fed
policy also continued to evolve in the closing weeks of the year, as the U.S.
central bank signalled it will slow its bond purchases at a quicker pace and
that it has "pencilled in the potential for three rate hikes next year."
Markets encountered bouts of volatility in the beginning stages of 2022 as
rising interest rates, high inflation and human tragedy in Europe were of the
utmost concern. U.S. equities, as represented by the S&P 500 Index, declined
4.6% in the first quarter of 2022. The S&P 500 recorded its worst January since
2009 and officially hit correction territory (a 10%+ decline) in February,
before rallying higher in March to close out the 3-month period. The Fed struck
an increasingly aggressive tone during the quarter, as inflation figures hit
40-year highs and Russian sanctions intensified supply-driven price pressures
across oil & gas, industrial metals and various agricultural commodities. The
U.S. central bank officially began its hiking cycle with a quarter-point
increase in March, the first since 2018, and the Fed's projections indicate
that the federal funds rate could reach 3.8% by the end of 2023. Equities
lagged in April as tighter monetary policy, geopolitical tensions in Europe and
lockdowns in China unfolded. The S&P 500 Index dropped 8.7% during the month of
April - the largest monthly decline since March 2020. In terms of style, value
stocks outperformed growth stocks as the Russell 1000 Value Index declined 3.9%
and the Russell 1000 Growth Index declined 17.8% during the semi-annual period.
Portfolio overview
The largest contributor to relative performance was stock selection and
allocation decisions in communication services. Within the sector, stock
selection and an overweight to the wireless telecom services industry accounted
for the majority of relative outperformance. In information technology (IT),
stock selection in the software and IT services industries boosted relative
returns. Furthermore, stock selection in energy proved beneficial mainly due to
our investment decisions in the oil, gas and consumable fuels industry.
The largest detractor from relative performance was in the consumer
discretionary sector. Within the sector, our overweight allocation and stock
selection in the automobiles industry accounted for the majority of
underperformance. Allocation decisions in the household durables industry also
proved costly within the sector. In financials, our stock selection in the
insurance industry proved detrimental, as did our decision not to invest in the
diversified financial services industry. Lastly, performance in the consumer
staples sector detracted from relative results, mainly due to investment
decisions in the household products industry.
Below is a comprehensive overview of our allocations (in British Pounds
Sterling) at the end of the period.
Information Technology: 5.7% overweight (14.9% of the portfolio)
The portfolio's largest overweight allocation is to the information technology
sector and we are finding ample investment opportunities due to the strong need
for tech. An increasing number of companies in the technology sector are what
we refer to as "industrial tech". These firms are competitively insulated from
disruptors, well-positioned to take advantage of long-term secular tailwinds,
and exhibit growth in earnings and free cash flow (FCF). Strong earnings growth
and FCF generation is also translating to an increasing number of companies
paying growing dividends to shareholders. Our preferred exposures in the sector
include communications equipment and IT services companies with sticky revenue
streams such as Cisco Systems (3.1% of the portfolio), Cognizant Technology
Solutions (2.6% of the portfolio) and Fidelity National Information Services
(2.1% of the portfolio). We also continue to invest in software companies with
capital-light business models such as Microsoft (2.1% of the portfolio) and SS&
C Technologies Holdings (2.0% of the portfolio). IT broadly scores well on
Environmental, Social and Governance (ESG) metrics given the generally lower
environmental impact than other sectors, with our selection of companies
including a mix of ESG leaders (Microsoft and Cisco Systems) and ESG improvers
(Fidelity National Information Services and SS&C Technologies).
Consumer Discretionary: 4.5% overweight (9.6% of the portfolio)
While there are concerns around higher inflation, higher wages and higher
shipping costs, the current market environment is unique as U.S. household
balance sheets are strong. Within the sector, our preferred areas of investment
include apparel, retail and firms with auto-related exposure. Disruption risks
persist in the sector and we believe these risks are best mitigated through
identifying stock-specific investment opportunities that either trade at
discounted valuations or have business models that are somewhat insulated from
disruptive pressures. For example, we believe companies such as Ralph Lauren
(2.3% of the portfolio) and General Motors (1.7% of the portfolio) offer
investors exposure to underappreciated franchises at discounted valuations.
Furthermore, retailers such as Dollar General (1.4% of the portfolio) provide
us with access to businesses that can potentially compound earnings and are
more immune to disruptive forces. From a sustainability standpoint, our
selection of companies includes a mix of ESG leaders such as Panasonic (2.0% of
the portfolio), as well as ESG improvers with clear roadmaps for better ESG
adherence and disclosures (i.e. Ralph Lauren's Global Citizen initiative and
General Motors' commitment to electric vehicles).
Financials: 0.5% overweight (20.3% of the portfolio)
Financials represent our portfolio's largest absolute sector allocation and we
remain particularly bullish on companies in the banks, insurance and wealth
management industries. The U.S. banks offer investors a combination of strong
balance sheets (their capital levels are meaningfully higher post financial
crisis), attractive valuations and the potential for relative upside versus the
broader market from inflation and higher interest rates. Secondly, we continue
to like insurers and insurance brokers, including American International Group,
Willis Towers Watson, First American and Fidelity National, as these companies
operate relatively stable businesses and trade at attractive valuations. We
categorise most of our holdings in this space as ESG improvers, with
opportunities for company management teams to enact stronger corporate
governance and human capital development policies. Lastly, we have also
identified stock specific investments in wealth management, as companies such
as Morgan Stanley (1.3% of the portfolio) and Charles Schwab (1.3% of the
portfolio) stand out from peers due to their differentiated investment
platforms, proximity to end customers and runways for long-term growth.
Materials: 2.7% overweight (6.8% of the portfolio)
Our exposure to the materials sector is stock specific. In the metals & mining
industry we have positions in Newmont (1.8% of the portfolio), an advantaged
gold miner that operates on the lower end of the cost curve, and in Steel
Dynamics (1.6% of the portfolio), the fifth largest U.S. steel producer. Both
are ESG leaders in their respective disciplines. Steel Dynamics is an EAF
(electric arc furnace) "clean" steel producer and EAF mills use a lower-cost,
less carbon-intensive process for manufacturing steel than conventional blast
furnaces. Meanwhile, Newmont stands above its gold mining peers due to its
strong governance, safety record and environmental management commitments. We
also recently initiated a position in Sealed Air (1.7% of the portfolio), a
manufacturer of film packaging for perishable food and industrials/e-commerce.
Sealed Air operates a high return business, has good pricing power and offers a
relatively stable growth outlook. From a sustainability standpoint, plastic
packagers generally score poorly on waste and water stress. The key issue for
plastic is how to improve circularity and management has pledged to have 100%
recyclable/reusable solutions and 50% average recycled/renewable content by
2025, which is well ahead of peers.
Health Care: 0.9% overweight (19.4% of the portfolio)
Secular growth opportunities in health care are a byproduct of demographic
trends. Older populations spend more on health care than younger populations.
In the United States, a combination of greater demand for health care services
and rising costs facilitates a need for increased efficiency within the health
care ecosystem. We believe innovation and strong cost control can work together
to address this need and companies that can contribute to this outcome may be
poised to benefit. On the innovation front, we are finding opportunities in
pharmaceuticals and among companies in the health care equipment & supplies
industry. We prefer to invest in pharma companies with a proven ability to
generate high research & development productivity versus those that focus on
one or two key drugs and rely upon raising their prices to drive growth.
Outside of pharma, our search for attractively priced innovators is more stock
specific as we like Alcon (1.4% of the portfolio), a leading eye care company
that serves more than 140 countries, and Dentsply Sirona (2.1% of the
portfolio), a dental manufacturer focused on both equipment and consumables.
From a cost perspective, health maintenance organisations (HMOs) have an
economic incentive to drive down costs, as they provide health insurance
coverage to constituents. These efforts ultimately help to make health care
insurance affordable to more people and the HMOs also play a substantial role
in improving the access to and quality of health care their members receive.
Fundamentally, we believe our holdings in the space can benefit from downward
pressure on cost-trend, new membership growth and further industry
consolidation over time. Furthermore, they trade at meaningfully discounted
valuations versus peers, offering us an attractive risk versus reward
opportunity.
Utilities: 0.5% underweight (5.0% of the portfolio)
Portfolio exposures are stock specific, as we are finding pockets of investment
opportunity among U.S. regulated utilities, which add a level of stability and
defensiveness to the portfolio through their durable earnings and dividend
profiles. Our investments in the sector primarily focus on ESG leaders that
have specific targets for reduction in carbon dioxide emissions (CO2) and
maintain significant exposure to renewables or generate power through cleaner
means such as natural gas.
Energy: 0.2% overweight (7.6% of the portfolio)
The Company currently invests in four energy stocks and we have a neutral
weight in the sector relative to the reference index. Our focus on
sustainability places a high hurdle for energy companies to be included in the
portfolio, but we believe the sector remains investable, as more traditional
oil & gas operators are critical in the energy transition towards less carbon
intensive sources. For example, natural gas is 40% to 60% less carbon-intensive
to produce and combust versus coal and oil. We have a bullish outlook on U.S.
natural gas due to the imposed Russian sanctions. We view natural gas as a key
"bridge fuel" and like companies such as Woodside Petroleum (2.0% of the
portfolio) and EQT (2.0% of the portfolio). Fundamentally, we generally seek to
invest in attractively priced operators with good resource assets that have the
opportunity to improve upon environmental issues or demonstrate clear
leadership in sustainability (i.e. through their exposure to renewables or
commitments to net zero/carbon neutral outcomes). We also prefer to target
companies with experienced management teams, low financial leverage and
disciplined capex spending plans, as these elements can contribute to positive
free cash flow generation over time.
Communication Services: 0.6% underweight (6.1% of the portfolio)
The portfolio has an underweight to communication services. Our underweight is
driven by expensive valuations and a lack of dividend payers in the
entertainment and interactive media & services industries. Meanwhile, the
portfolio is overweight to the diversified telecommunication services and
wireless telecom services industries. Notable portfolio holdings include
Verizon Communications (diversified telecom; 3.1% of the portfolio) and Rogers
Communications (wireless telecom; 2.2% of the portfolio). Verizon
Communications and Rogers Communications trade at reasonable valuations, boast
strong competitive positions and rank well on ESG metrics versus peers. We also
like that their core businesses, operating telecom networks, can be a key
enabler of smart cities of the future, with potential to reduce energy
consumption and provide other social benefits.
Consumer Staples: 3.0% underweight (5.1% of the portfolio)
The consumer staples sector is a common destination for the conservative equity
income investor. Historically, many of these companies have offered investors
recognisable brands, diverse revenue streams, exposure to growing end markets
and the ability to garner pricing power. These characteristics, in turn, have
translated into strong and often stable free cash flow and growing dividends
for shareholders. In recent years some of these secular advantages have become
challenged, in our view, due to changing consumer preferences, greater end
market competition from local brands and disruption from the rapid adoption of
online shopping. These challenges, combined with higher than historical
valuations, have facilitated our underweight positioning in the sector. Notable
portfolio holdings include PepsiCo (2.4% of the portfolio) and Lamb Weston
Holdings (0.8% of the portfolio). We view each of these businesses as ESG
leaders: PepsiCo stands out for reducing its water usage and product carbon
footprint; and Lamb Weston Holdings is at the forefront of implementing strong
corporate governance practices.
Real Estate: 4.2% underweight (0.9% of the portfolio)
The portfolio has an underweight allocation to real estate, as we are finding
few companies in the sector with both attractive valuations and strong or
improving fundamentals. For example, retail REITs are facing challenges due to
e-commerce and its negative impact on traditional brick and mortar retailers.
Meanwhile, data center and logistics companies have strong fundamentals, but we
view their valuations as unattractive. Our one portfolio holding is SL Green
Realty (0.9% of the portfolio), an office REIT with a knowledgeable management
team that has successfully navigated the New York City real estate cycle and,
in our view, made astute capital allocation decisions over time. SL Green
Realty is the largest New York City (NYC) landlord and over 90% of its office
footprint is Leadership in Energy and Environmental Design (LEED) Gold or
Silver certified, well above the NYC and U.S. averages. LEED is a leading
rating system for sustainable and "green" buildings and the certification is
administered by the U.S. Green Building Council, a private non-profit
organisation.
Industrials: 6.2% underweight (4.3% of the portfolio)
The portfolio is meaningfully underweight to the industrials sector. Our
selectivity is driven by relative valuations, which we view as expensive, in
many cases, versus other cyclical value segments of the U.S. equity market.
Notable positions include Komatsu (2.6% of the portfolio), a Japanese
manufacturer of construction and mining equipment, and Norfolk Southern (1.7%
of the portfolio), a major U.S. east coast railroad operator. We view both
companies as ESG leaders in their respective domains. Komatsu has set
meaningful targets for reduced CO2 emissions from its products by 2030 and to
achieve carbon neutrality by 2050. Furthermore, Norfolk Southern provides us
with exposure to a consolidated industry with pricing power that emits roughly
one-third as much CO2 as trucks (the main shipping alternative), in moving an
equivalent amount of cargo.
Market outlook
A fast-paced economic cycle, one born in the depths of the pandemic and shaped
by coordinated monetary and fiscal policy stimulus, continued its forward
charge in the first quarter. A grievous war has applied new pressures to a
global financial system that is looking to normalise interest rates and process
the effects of the highest inflation seen in decades. The investing backdrop is
mired in uncertainty, but one matter we feel relatively confident about is that
U.S. markets are going through a regime change. The post-global financial
crisis (post-GFC) era marked by low to moderate economic growth, low inflation
and lower interest rates, is over. In its place is an environment still taking
form, but one that will undoubtedly entail higher inflation and rates than we
experienced from 2008 to 2020. Although we do not see inflation sustaining at
the current decades-high level over the long term, we do expect it to settle
into a range higher than the sub-2% seen in the post-GFC period. The culprits,
among others, are a tight U.S. labour market and a shortage of entry-level
homes, which could apply persistent upward pressure on the costs for services
and shelter. This form of "sticky" inflation can be more enduring than other
inflation pressures where a rebalance of supply and demand can more quickly
restore price stability. From an investment standpoint, higher inflation will
challenge companies' cost structures, and investors must discern which
businesses are most impacted by rising costs and which have the pricing power
to maintain their profit margins.
Volatile markets can test investors' fortitude and we believe these are the
moments when active, bottom-up stock selection and thoughtful portfolio
construction can provide a steady hand in pursuit of long-term financial goals.
In the Company, we continue to use a barbell approach in pursuit of portfolio
resilience. We are identifying companies in health care and technology with
good stability characteristics and companies in financials and energy with
cheaper valuations that are well-positioned for a Fed hiking cycle. Another
overarching theme in the portfolio is a focus on quality - particularly stocks
of companies with strong balance sheets and healthy free cash flow
characteristics. This posture has served us well in recent years and we
continue to view it as prudent in navigating today's unique market backdrop.
Tony DeSpirito, David Zhao and Lisa Yang
BlackRock Investment Management LLC
29 June 2022
Ten largest investments
1 + AstraZeneca (2021: 2nd)
Sector: Health Care
Market value: £6,613,000
Share of investments: 3.7% (2021: 3.5%)
ESG Leader
AstraZeneca is a diversified pharmaceutical group that conducts research &
development (R&D) in high growth areas including oncology, cardiovascular
diseases and immunology. It is also a leader in increasing access to health
care in the developing world and we are encouraged by the aggressive stance it
has taken on addressing its carbon footprint. AstraZeneca has improved its R&D
productivity and cost control in recent years and we believe the group now has
a long runway for top-line and bottom-line growth.
2 + Sanofi (2021: 12th)
Sector: Health Care
Market value: £5,868,000
Share of investments: 3.3% (2021: 2.3%)
ESG Leader
Sanofi is a multinational health care group that operates in pharmaceuticals,
vaccines and consumer health. The group is a leader in diabetes, immunology and
branded generics. Additionally, the group has a wide portfolio of vaccines and
maintains strong consumer brands such as Allegra, Gold Bond and Icy Hot. The
group is a leader in various initiatives aimed at addressing global health
inequality issues. The group is strongly committed to eradicating various
diseases including polio and sleeping sickness by 2030 and aims to develop
innovative therapies to address childhood cancers.
3 - Cisco Systems (2021: 1st)
Sector: Information Technology
Market value: £5,567,000
Share of investments: 3.1% (2021: 4.0%)
ESG Leader
Cisco Systems (Cisco) is the world's largest networking equipment vendor, with
leading positions in most of its core end markets. As one of the largest
suppliers of network security solutions, Cisco's products help customers to
enhance data security and privacy. Despite market concerns regarding
competition and cloud migration, we believe it can still deliver sustainable
revenue and earnings growth due to better than feared market positions, a
diversified portfolio and a large existing installed base.
4 + Verizon Communications (2021: 14th)
Sector: Communication Services
Market value: £5,541,000
Share of investments: 3.1% (2021: 2.3%)
ESG Leader
Verizon Communications (Verizon) is the leading wireless group in the United
States. Verizon trades at a reasonable price relative to the quality and
stability of its business. The group's leadership has also continuously shown
interest in key social issues. For example, Verizon took pro-active measures to
survey and help improve employee mental health during the pandemic. The group
also incorporates metrics such as diversity and carbon intensity into
compensation.
5 + Anthem (2021: 11th)
Sector: Health Care
Market value: £5,156,000
Share of investments: 2.9% (2021: 2.5%)
ESG Leader
Anthem operates as the second largest managed care organisation under the
recognisable Blue Cross & Blue Shield brand. The group services members across
commercial, Medicare and Medicaid markets, while also operating a health care
services business. Under the leadership of Anthem's new CEO, we believe the
group is well-positioned to accelerate growth through various initiatives.
Managed care companies play a substantial role in improving access and quality
of health care to its members and in driving down costs to make health
insurance affordable to more people. Anthem provides exposure to the favourable
HMO growth trends at an attractive valuation.
6 + Sempra (2021: 37th)
Sector: Utilities
Market value: £5,129,000
Share of investments: 2.9% (2021: 1.4%)
ESG Leader
Sempra is a North American energy infrastructure group where 75% of the
business is a regulated utility with exposure to Southern California and Texas.
The remaining 25% is Sempra's Infrastructure Partners business, which includes
various assets including gas, pipelines, renewable generation and small
regulated gas utility. Sempra's gas investments are driven by safety and
emissions. The group also has a strong focus on electric transmissions and
distribution assets which reduces Sempra's risk exposure associated with
greenhouse gas emissions.
7 - Cognizant Technology Solutions (2021: 5th)
Sector: Information Technology
Market value: £4,635,000
Share of investments: 2.6% (2021: 3.2%)
ESG Leader
Cognizant Technology Solutions (Cognizant) is an IT Services group with a
diversified revenue base across industry verticals and geographies. As a
service provider, they help enterprise small and medium business clients to
transition to cloud infrastructure, which is more efficient versus sub-scale
in-house data centers. The group also exhibits strong governance as evidenced
by an independent chairman, an independent majority and a gender diverse board.
After a period of market share loss and earnings guide-downs, we do not believe
Cognizant is structurally impaired. Rather, we see an attractive turnaround
opportunity under CEO Brian Humphries (who joined the firm in April 2019).
8 - Comerica (2021: 3rd)
Sector: Financials
Market value: £4,581,000
Share of investments: 2.6% (2021: 3.4%)
ESG Leader
Comerica is one of the 20 largest U.S. banks and most of their business is in
commercial loans. It has a strong independent risk management committee that
focuses on detecting unethical behaviour and has established processes to
attract and retain talent, including a focus on diversity. We see Comerica as
offering us access to higher growth geographies in the US and believe its
significant excess capital above regulatory minimums can help them execute on
their long-term goals.
9 - Komatsu (2020: 6th)
Sector: Industrials
Market value: £4,579,000
Share of investments: 2.6% (2021: 3.0%)
ESG Leader
Komatsu is a Japanese manufacturer of construction and mining equipment and a
provider of aftermarket parts and services. Lax management has left Komatsu
underperforming its potential, but we believe sales are at a cyclical trough
and that forward estimates are too low (i.e. the sales recovery following the
pandemic is underappreciated). From a sustainability standpoint, the group is a
leader in incorporating a broad range of power sources (i.e. hybrids, hydrogen,
trolley, battery-electric) in its product portfolio. Furthermore, the group's
management has set targets to reduce CO2 emissions from its products by 50% by
2030 and to achieve carbon neutrality by 2050.
10 - Wells Fargo (2021: 4th)
Financials
Market value: £4,560,000
Share of investments: 2.6% (2021: 3.3%)
ESG Improver
Wells Fargo (WFC) is one of the largest U.S. banks and it operates in three
segments including community banking, wholesale banking and wealth & investment
management. The group has a strong deposit franchise and we like its history of
strong investment returns and prudent credit risk management. While WFC has a
chequered history, we believe its current management team, led by CEO Charlie
Scharf (hired in October 2019), can restore the firm's reputation as a premier
community bank. Operational improvements require patience, but we believe that
risk and control remediation, as well as time-passed, can ultimately improve
WFC's low social and governance scores. In summary, we view shares of the group
as underappreciated today in an environment characterised by low credit losses
and ample access to liquidity.
All percentages reflect the value of the holding as a percentage of total
investments.
Percentages in brackets represent the value of the holding as at 31 October
2021.
Together, the ten largest investments represent 29.4% of the Company's
portfolio (31 October 2021: 31.7%).
ESG Leaders: best-in-class companies that effectively manage ESG factors to
benefit all stakeholders.
ESG Improvers: companies showing demonstrable progress in their ESG journey.
Portfolio analysis as at 30 April 2022
% % % % % % % % % 30.04.22 31.10.21
Canada France Switzerland United Kingdom United States Japan Australia Denmark Norway Total Total
Sectors % %
Financials - - - - 20.3 - - - - 20.3 25.4
Health Care - 3.3 1.4 3.7 10.5 - - 0.5 - 19.4 18.6
Information - - - - 14.9 - - - - 14.9 14.9
Technology
Consumer - - - - 7.6 2.0 - - - 9.6 11.3
Discretionary
Energy - - - - 5.6 - 2.0 - - 7.6 5.3
Materials - - - - 6.8 - - - - 6.8 3.8
Communication 2.2 - - - 3.9 - - - - 6.1 5.8
Services
Consumer - - - 1.9 3.2 - - - - 5.1 3.9
Staples
Utilities - - - - 5.0 - - - - 5.0 5.2
Industrials - - - - 1.7 2.6 - - - 4.3 4.9
Real Estate - - - - 0.9 - - - - 0.9 0.9
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
% Portfolio 2.2 3.3 1.4 5.6 80.4 4.6 2.0 0.5 - 100.0
30.04.22
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
% Portfolio 2.7 3.2 1.9 3.5 79.5 4.8 1.3 1.3 1.8 100.0
31.10.21
========= ========= ========= ========= ========= ========= ========= ========= ========= ========= =========
Investments as at 30 April 2022
Market
value % of
Company Country Sector £'000 total portfolio
AstraZeneca United Health Care 6,613 3.7
Kingdom
Sanofi France Health Care 5,868 3.3
Cisco Systems United Information 5,567 3.1
States Technology
Verizon Communications United Communication 5,541 3.1
States Services
Anthem United Health Care 5,156 2.9
States
Sempra United Utilities 5,129 2.9
States
Cognizant Technology Solutions United Information 4,635 2.6
States Technology
Comerica United Financials 4,581 2.6
States
Komatsu Japan Industrials 4,579 2.6
Wells Fargo United Financials 4,560 2.6
States
Cigna United Health Care 4,513 2.6
States
Willis Towers Watson United Financials 4,509 2.6
States
American International Group United Financials 4,427 2.5
States
PepsiCo United Consumer 4,286 2.4
States Staples
Laboratory Corporation of America United Health Care 4,162 2.4
States
Ralph Lauren United Consumer 4,070 2.3
States Discretionary
Citigroup United Financials 4,046 2.3
States
Rogers Communications Canada Communication 3,910 2.2
Services
Fidelity National Information Services United Information 3,781 2.1
States Technology
Public Service Enterprise Group United Utilities 3,762 2.1
States
Hess United Energy 3,713 2.1
States
Microsoft United Information 3,691 2.1
States Technology
Dentsply Sirona United Health Care 3,624 2.1
States
EQT United Energy 3,598 2.0
States
CDK Global United Information 3,582 2.0
States Technology
Panasonic Japan Consumer 3,494 2.0
Discretionary
SS&C Technologies Holdings United Information 3,473 2.0
States Technology
Woodside Petroleum Australia Energy 3,458 2.0
Reckitt Benckiser Group United Consumer 3,284 1.9
Kingdom Staples
Newmont United Materials 3,249 1.8
States
General Motors United Consumer 3,035 1.7
States Discretionary
Sealed Air United Materials 2,983 1.7
States
PPG Industries United Materials 2,933 1.7
States
Norfolk Southern United Industrials 2,930 1.7
States
Steel Dynamics United Materials 2,886 1.6
States
Bank of America United Financials 2,765 1.6
States
ConocoPhillips United Energy 2,625 1.5
States
Alcon Switzerland Health Care 2,543 1.4
Dollar General United Consumer 2,461 1.4
States Discretionary
Newell Brands United Consumer 2,458 1.4
States Discretionary
Morgan Stanley United Financials 2,334 1.3
States
Charles Schwab United Financials 2,282 1.3
States
Invesco United Financials 2,270 1.3
States
Visa United Information 1,700 1.0
States Technology
SL Green Realty United Real Estate 1,616 0.9
States
First American United Financials 1,609 0.9
States
Warner Bros. Discovery United Communication 1,481 0.8
States Services
Lear United Consumer 1,435 0.8
States Discretionary
Lamb Weston Holdings United Consumer 1,399 0.8
States Staples
Fidelity National United Financials 1,314 0.7
States
JPMorgan Chase United Financials 993 0.6
States
Novo Nordisk Denmark Health Care 897 0.5
AmerisourceBergen United Health Care 855 0.5
States
--------------- ---------------
Portfolio 176,665 100.0
========= =========
All investments are in ordinary shares. The number of holdings as at 30 April
2022 was 53 (31 October 2021: 54).
At 30 April 2022, the Company did not hold any equity interests comprising more
than 3% of any company's share capital.
Interim Management Report and Responsibility Statement
The Chairman's Statement and Investment Manager's Report above give details of
the important events which have occurred during the period and their impact on
the financial statements.
Principal risks and uncertainties
The principal risks faced by the Company can be divided into various areas as
follows:
· Counterparty;
· Investment performance;
· Legal & Regulatory Compliance;
· Market;
· Operational;
· Political;
· Financial; and
· Marketing.
The Board reported on the principal risks and uncertainties faced by the
Company in the Annual Report and Financial Statements for the year ended 31
October 2021. A detailed explanation can be found in the Strategic Report on
pages 35 to 38 and in note 14 on pages 91 to 100 of the Annual Report and
Financial Statements which are available on the website maintained by BlackRock
at www.blackrock.com/uk/brsa.
The ongoing COVID-19 pandemic has had a profound impact on all aspects of
society in recent years. The impact of this significant event on the Company's
financial risk exposure is disclosed in note 10.
The Directors have assessed the impact of market conditions arising from the
COVID-19 outbreak on the Company's ability to meet its investment objective.
Based on the latest available information, the Company continues to be managed
in line with its investment objective, with no disruption to its operations.
Certain financial markets have fallen towards the end of the financial period
due primarily to geo-political tensions arising from Russia's invasion of
Ukraine and the impact of the subsequent range of sanctions, regulations and
other measures which impaired normal trading in Russian securities. The Board
and the Investment Manager continue to monitor investment performance in line
with the Company's investment objectives, and the operations of the Company and
the publication of net asset values are continuing.
In the view of the Board, there have not been any changes to the fundamental
nature of the principal risks and uncertainties since the previous report and
these are equally applicable to the remaining six months of the financial year
as they were to the six months under review.
Going concern
The Board remains mindful of the ongoing uncertainty surrounding the potential
duration of the COVID-19 pandemic and its longer-term effects on the global
economy and the current heightened geo-political risk. Nevertheless, the
Directors, having considered the nature and liquidity of the portfolio, the
Company's investment objective and the Company's projected income and
expenditure, are satisfied that the Company has adequate resources to continue
in operational existence for the foreseeable future and is financially sound.
The Board is still mindful of the continuing uncertainty surrounding the
potential duration of the COVID-19 pandemic and its longer-term effects on the
global economy and recovery of economies. The Board believes that the Company
and its key third-party service providers have in place appropriate business
continuity plans and these services have continued to be supplied without
interruption throughout the COVID-19 pandemic.
The Company has a portfolio of investments which are predominantly readily
realisable and is able to meet all its liabilities from its assets and income
generated from these assets. Accounting revenue and expense forecasts are
maintained and reported to the Board regularly and it is expected that the
Company will be able to meet all its obligations. Borrowings under the
overdraft facility shall at no time exceed 20% of the Company's net assets
(calculated at the time of draw down), although the Board intends only to
utilise borrowings representing 10% of net assets at the time of draw down, and
this covenant was complied with during the period. Ongoing charges for the year
ended 31 October 2021 were 1.06% of net assets and are expected to fall
modestly going forward.
Based on the above, the Board is satisfied that it is appropriate to continue
to adopt the going concern basis in preparing the financial statements.
Related party disclosure and transactions with the Manager
BlackRock Fund Managers Limited (BFM) was appointed as the Company's
AIternative Investment Fund Manager (AIFM) with effect from 2 July 2014. BFM
has (with the Company's consent) delegated certain portfolio and risk
management services, and other ancillary services, to BlackRock Investment
Management (UK) Limited (BIM (UK)). Both BFM and BIM (UK) are regarded as
related parties under the Listing Rules. Details of the fees payable are set
out in note 4 and note 11 below.
The related party transactions with the Directors are set out in note 12 below.
Directors' responsibility statement
The Disclosure Guidance and Transparency Rules (DTR) of the UK Listing
Authority require the Directors to confirm their responsibilities in relation
to the preparation and publication of the Interim Management Report and
Financial Statements.
The Directors confirm to the best of their knowledge that:
· the condensed set of financial statements contained within the Half
Yearly Financial Report has been prepared in accordance with applicable
International Accounting Standard 34 - 'Interim Financial Reporting'; and
· the Interim Management Report, together with the Chairman's Statement
and Investment Manager's Report, include a fair review of the information
required by 4.2.7R and 4.2.8R of the FCA's Disclosure Guidance and Transparency
Rules.
This Half Yearly Financial Report has not been audited or reviewed by the
Company's auditors.
The Half Yearly Financial Report was approved by the Board on 29 June 2022 and
the above responsibility statement was signed on its behalf by the Chairman.
Simon Miller
FOR AND ON BEHALF OF THE BOARD
29 June 2022
Statement of Comprehensive Income for the six months ended 30 April 2022
Six months ended Six months ended Year ended
30 April 2022 30 April 2021 31 October 2021
(unaudited) (unaudited) (audited)
Revenue Capital Total Revenue Capital Total Revenue Capital Total
Notes £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000
Income from investments 3 1,961 47 2,008 1,777 2 1,779 3,617 2 3,619
held at fair value through
profit or loss
Other income 3 - - - 939 - 939 897 - 897
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Total revenue 1,961 47 2,008 2,716 2 2,718 4,514 2 4,516
========= ========= ========= ========= ========= ========= ========= ========= =========
Net profit on investments - 9,038 9,038 - 33,953 33,953 - 42,989 42,989
and options held at fair
value through profit or
loss
Net loss on foreign - (199) (199) - (596) (596) - (653) (653)
exchange
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Total 1,961 8,886 10,847 2,716 33,359 36,075 4,514 42,338 46,852
========= ========= ========= ========= ========= ========= ========= ========= =========
Expenses
Investment management fee 4 (148) (444) (592) (138) (414) (552) (284) (853) (1,137)
Other operating expenses 5 (153) 2 (151) (242) (5) (247) (547) (13) (560)
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Total operating expenses (301) (442) (743) (380) (419) (799) (831) (866) (1,697)
========= ========= ========= ========= ========= ========= ========= ========= =========
Net profit on ordinary 1,660 8,444 10,104 2,336 32,940 35,276 3,683 41,472 45,155
activities before finance
costs and taxation
Finance costs (4) (11) (15) - - - - - -
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Net profit on ordinary 1,656 8,433 10,089 2,336 32,940 35,276 3,683 41,472 45,155
activities before taxation
Taxation (charge)/credit (193) - (193) (294) 79 (215) (435) 14 (421)
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Net profit on ordinary 1,463 8,433 9,896 2,042 33,019 35,061 3,248 41,486 44,734
activities after taxation
========= ========= ========= ========= ========= ========= ========= ========= =========
Earnings per ordinary 7 1.82 10.51 12.33 2.56 41.36 43.92 4.06 51.84 55.90
share (pence)
========= ========= ========= ========= ========= ========= ========= ========= =========
The total column of this statement represents the Company's Statement of
Comprehensive Income, prepared in accordance with UK-adopted International
Accounting Standards (IASs). The supplementary revenue and capital accounts are
both prepared under guidance published by the Association of Investment
Companies (AIC). All items in the above statement derive from continuing
operations. No operations were acquired or discontinued during the period. All
income is attributable to the equity holders of the Company.
The Company does not have any other comprehensive income. The net profit for
the period disclosed above represents the Company's total comprehensive income.
Statement of Changes in Equity for the six months ended 30 April 2022
Called Share Capital
up share premium redemption Special Capital Revenue
capital account reserve reserve reserves reserve Total
Note £'000 £'000 £'000 £'000 £'000 £'000 £'000
For the six months ended 30
April 2022 (unaudited)
At 31 October 2021 1,004 44,873 1,460 38,090 79,369 538 165,334
Total comprehensive income:
Net profit for the period - - - - 8,433 1,463 9,896
Transactions with owners,
recorded directly to equity:
Dividends paid1 6 - - - - (1,394) (1,815) (3,209)
--------------- --------------- --------------- --------------- --------------- --------------- ---------------
At 30 April 2022 1,004 44,873 1,460 38,090 86,408 186 172,021
========= ========= ========= ========= ========= ========= =========
For the six months ended 30
April 2021 (unaudited)
At 31 October 2020 1,004 44,533 1,460 37,839 38,222 3,352 126,410
Total comprehensive income:
Net profit for the period - - - - 33,019 2,042 35,061
Transactions with owners,
recorded directly to equity:
Ordinary shares reissued from - 340 - 548 - - 888
treasury
Share issue costs - - - (2) - - (2)
Ordinary shares bought back - - - (294) - - (294)
into treasury
Share purchase costs - - - (1) - - (1)
Dividends paid2 - - - - - (3,192) (3,192)
--------------- --------------- --------------- --------------- --------------- --------------- ---------------
At 30 April 2021 1,004 44,873 1,460 38,090 71,241 2,202 158,870
========= ========= ========= ========= ========= ========= =========
For the year ended 31 October
2021 (audited)
At 31 October 2020 1,004 44,533 1,460 37,839 38,222 3,352 126,410
Total comprehensive income:
Net profit for the year - - - - 41,486 3,248 44,734
Transactions with owners,
recorded directly to equity:
Ordinary shares reissued from - 340 - 548 - - 888
treasury
Share issue costs - - - (2) - - (2)
Ordinary shares bought back - - - (294) - - (294)
into treasury
Share purchase costs - - - (1) - - (1)
Dividends paid3 - - - - (339) (6,062) (6,401)
--------------- --------------- --------------- --------------- --------------- --------------- ---------------
At 31 October 2021 1,004 44,873 1,460 38,090 79,369 538 165,334
========= ========= ========= ========= ========= ========= =========
1 4th interim dividend of 2.00p per share for the year ended 31 October
2021, declared on 3 November 2021 and paid on 4 January 2022 and 1st interim
dividend of 2.00p per share for the year ending 31 October 2022, declared on 22
March 2022 and paid on 29 April 2022.
2 4th interim dividend of 2.00p per share for the year ended 31 October
2020, declared on 4 November 2020 and paid on 4 January 2021 and 1st interim
dividend of 2.00p per share for the year ending 31 October 2021, declared on 23
March 2021 and paid on 29 April 2021.
3 4th interim dividend of 2.00p per share for the year ended 31 October
2020, declared on 4 November 2020 and paid on 4 January 2021; 1st interim
dividend of 2.00p per share for the year ended 31 October 2021, declared on 23
March 2021 and paid on 29 April 2021; 2nd interim dividend of 2.00p per share
for the year ended 31 October 2021, declared on 5 May 2021 and paid on 2 July
2021; and 3rd interim dividend of 2.00p per share for the year ended 31 October
2021, declared on 5 August 2021 and paid on 1 October 2021.
For information on the Company's distributable reserves, please refer to note 9
below.
Statement of Financial Position as at 30 April 2022
30 April 30 April 31 October
2022 2021 2021
(unaudited) (unaudited) (audited)
Notes £'000 £'000 £'000
Non current assets
Investments held at fair value through profit or 10 176,665 148,432 164,971
loss
Current assets
Current tax asset 99 83 96
Other receivables 332 2,185 2,243
Cash and cash equivalents 60 10,681 1,240
--------------- --------------- ---------------
Total current assets 491 12,949 3,579
========= ========= =========
Total assets 177,156 161,381 168,550
========= ========= =========
Current liabilities
Current tax liability - (35) -
Other payables (1,389) (1,591) (3,216)
Derivative financial liabilities held at fair value - (885) -
through profit or loss
Bank overdraft (3,746) - -
--------------- --------------- ---------------
Total current liabilities (5,135) (2,511) (3,216)
========= ========= =========
Net assets 172,021 158,870 165,334
========= ========= =========
Equity attributable to equity holders
Called up share capital 8 1,004 1,004 1,004
Share premium account 44,873 44,873 44,873
Capital redemption reserve 1,460 1,460 1,460
Special reserve 38,090 38,090 38,090
Capital reserves 86,408 71,241 79,369
Revenue reserve 186 2,202 538
--------------- --------------- ---------------
Total equity 172,021 158,870 165,334
========= ========= =========
Net asset value per ordinary share (pence) 7 214.41 198.02 206.08
========= ========= =========
Cash Flow Statement for the six months ended 30 April 2022
Six months Six months Year
ended ended ended
30 April 30 April 31 October
2022 2021 2021
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
Operating activities
Net profit on ordinary activities before taxation 10,089 35,276 45,155
Add back finance costs 15 - -
Net profit on investments and options held at fair value (9,038) (33,955) (42,989)
through profit or loss (including transaction costs)
Net loss on foreign exchange 199 596 653
Sales of investments held at fair value through profit or 50,798 66,354 199,237
loss
Purchases of investments held at fair value through profit or (53,454) (60,860) (202,133)
loss
(Increase)/decrease in other receivables (116) (365) 35
Increase in other payables 173 269 143
Decrease/(increase) in amounts due from brokers 2,021 (1,056) (1,514)
(Decrease)/increase in amounts due to brokers (2,000) (95) 1,656
--------------- --------------- ---------------
Net cash (outflow)/inflow from operating activities before (1,313) 6,164 243
taxation
Taxation paid (190) (355) (609)
--------------- --------------- ---------------
Net cash (outflow)/inflow from operating activities (1,503) 5,809 (366)
========= ========= =========
Financing activities
Interest paid (15) - -
Net cash proceeds from ordinary shares reissued from treasury - 886 886
Net cash outflow from ordinary shares bought back into - (295) (295)
treasury
Dividends paid (3,209) (3,192) (6,401)
--------------- --------------- ---------------
Net cash outflow from financing activities (3,224) (2,601) (5,810)
========= ========= =========
(Decrease)/increase in cash and cash equivalents (4,727) 3,208 (6,176)
Effect of foreign exchange rate changes (199) (596) (653)
--------------- --------------- ---------------
Change in cash and cash equivalents (4,926) 2,612 (6,829)
Cash and cash equivalents at start of period/year 1,240 8,069 8,069
--------------- --------------- ---------------
Cash and cash equivalents at end of period/year (3,686) 10,681 1,240
========= ========= =========
Comprised of:
Cash at bank 60 10,681 666
Bank overdraft (3,746) - -
Cash Fund1 - - 574
--------------- --------------- ---------------
(3,686) 10,681 1,240
========= ========= =========
1 Cash Fund represents funds invested in the BlackRock Institutional Cash
Series plc - US Dollar Liquid Environmentally Aware Fund.
Notes to the financial statements for the six months ended 30 April 2022
1. PRINCIPAL ACTIVITY
The principal activity of the Company is that of an investment trust company
within the meaning of Section 1158 of the Corporation Tax Act 2010.
2. BASIS OF PRESENTATION
The half yearly financial statements for the period ended 30 April 2022 have
been prepared in accordance with the Disclosure Guidance and Transparency Rules
sourcebook of the Financial Conduct Authority and with the UK-adopted
International Accounting Standard 34 (IAS 34), 'Interim Financial Reporting'.
The half yearly financial statements should be read in conjunction with the
Company's Annual Report and Financial Statements for the year ended 31 October
2021, which have been prepared in accordance with International Accounting
Standards (IASs) in conformity with the requirements of the Companies Act 2006.
Insofar as the Statement of Recommended Practice (SORP) for investment trust
companies and venture capital trusts, issued by the Association of Investment
Companies (AIC) in October 2019 and updated in April 2021, is compatible with
UK-adopted IASs, the financial statements have been prepared in accordance with
guidance set out in the SORP.
Amendments to IFRS 9, IAS 39 and IFRS 7 - Interest rate benchmark reform Phase
2 (effective 1 January 2021). The Phase 2 amendments address issues that might
affect financial reporting during the reform of an interest rate benchmark,
including the effects of changes to contractual cash flows or hedging
relationships arising from the replacement of an interest rate benchmark with
an alternative benchmark rate (replacement issues).
The objectives of the Phase 2 amendments are to assist companies in:
* applying IFRS Standards when changes are made to contractual cash flows or
hedging relationships because of the interest rate benchmark reform; and
* providing useful information to users of financial statements.
In Phase 2 of its project, the Board amended requirements in IFRS 9 Financial
Instruments, IAS 39 Financial Instruments: Recognition and Measurement, IFRS 7
Financial Instruments: Disclosures, IFRS 4 Insurance Contracts and IFRS 16
Leases relating to:
* changes in the basis for determining contractual cash flows of financial
assets, financial liabilities and lease liabilities;
* hedge accounting; and
* disclosures.
The Phase 2 amendments apply only to changes required by the interest rate
benchmark reform to financial instruments and hedging relationships.
These amendments have been adopted by the UK. The adoption of these amendments
did not have any significant impact on the Company.
International Accounting Standards that have yet to be adopted:
IFRS 17 - Insurance contracts (effective 1 January 2023). This standard
replaces IFRS 4, which currently permits a wide range of accounting practices
in accounting for insurance contracts. IFRS 17 will fundamentally change the
accounting by all entities that issue insurance contracts and investment
contracts with discretionary participation features. This standard is unlikely
to have any impact on the Company as it has no insurance contracts.
IAS 12 - Deferred tax related to assets and liabilities arising from a single
transaction (effective 1 January 2023). The IASB has amended IAS 12, Income
taxes, to require companies to recognise deferred tax on particular
transactions that, on initial recognition, give rise to equal amounts of
taxable and deductible temporary differences. According to the amended
guidance, a temporary difference that arises on initial recognition of an asset
or liability is not subject to the initial recognition exemption if that
transaction gave rise to equal amounts of taxable and deductible temporary
differences. These amendments might have a significant impact on the
preparation of financial statements by companies that have substantial balances
of right-of-use assets, lease liabilities, decommissioning, restoration and
similar liabilities. The impact for those affected would be the recognition of
additional deferred tax assets and liabilities.
The amendment of this standard is unlikely to have any significant impact on
the Company.
3. INCOME
Six months Six months Year
ended ended ended
30 April 30 April 31 October
2022 2021 2021
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
Investment income:
UK dividends 148 168 297
Overseas dividends 1,764 1,536 3,228
Overseas special dividends 8 73 73
Overseas REIT dividends 41 - 19
--------------- --------------- ---------------
Total investment income 1,961 1,777 3,617
========= ========= =========
Other income:
Option premium income - 939 897
--------------- --------------- ---------------
- 939 897
========= ========= =========
Total income 1,961 2,716 4,514
========= ========= =========
During the period, the Company received no option premium income in cash (six
months ended 30 April 2021: £1,017,000; year ended 31 October 2021: £585,000)
for writing covered call options for the purposes of revenue generation.
Option premium income is amortised evenly over the life of the option contract.
During the period, no option premiums (six months ended 30 April 2021: £
939,000; year ended 31 October 2021: £897,000) were amortised to revenue.
At 30 April 2022, there were no open positions or associated liability (six
months ended 30 April 2021: 174 open positions with an associated liability of
£885,000; year ended 31 October 2021: no open positions or associated
liability).
All derivative transactions were based on constituent stocks in the Russell
1000 Value Index.
Dividends and interest received in cash during the period amounted to £
1,659,000 and £nil (six months ended 30 April 2021: £1,526,000 and £nil; year
ended 31 October 2021: £3,127,000 and £nil).
Special dividends of £47,000 have been recognised in capital during the period
(six months ended 30 April 2021: £2,000; year ended 31 October 2021: £2,000).
4. INVESTMENT MANAGEMENT FEE
Six months ended Six months ended Year ended
30 April 2022 30 April 2021 31 October 2021
(unaudited) (unaudited) (audited)
Revenue Capital Total Revenue Capital Total Revenue Capital Total
£'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000
Investment 148 444 592 138 414 552 284 853 1,137
management fee
--------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------------
Total 148 444 592 138 414 552 284 853 1,137
========= ========= ========= ========= ========= ========= ========= ========= =========
Up to 29 July 2021, the investment management fee was payable in quarterly
arrears, calculated at the rate of 0.75% of the Company's net assets. With
effect from 30 July 2021, the investment management fee is payable in quarterly
arrears, calculated at the rate of 0.70% of the Company's net assets. The
investment management fee is allocated 75% to the capital account and 25% to
the revenue account.
There is no additional fee for company secretarial and administration services.
5. OTHER OPERATING EXPENSES
Six months Six months Year
ended ended ended
30 April 30 April 31 October
2022 2021 2021
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
Allocated to revenue:
Custody fee 1 3 3
Auditors' remuneration - audit services1 19 19 38
Registrar's fee 15 15 32
Directors' emoluments 82 83 164
Broker fees 20 20 75
Depositary fees 8 7 14
Printing fees 16 18 44
Legal and professional fees 17 19 63
Marketing fees 17 18 37
AIC fees 5 4 9
FCA fees 4 4 8
Write back of prior year expenses2 (87) - -
Other administration costs 36 32 60
--------------- --------------- ---------------
153 242 547
========= ========= =========
Allocated to capital:
Custody transaction charges3 5 5 13
Write back of prior year expenses3,4 (7) - -
--------------- --------------- ---------------
151 247 560
========= ========= =========
1 No non-audit services were provided by the Company's auditors.
2 Relates to prior year accruals for Directors' fees, directors' expenses
and legal fees written back during the period.
3 For the six month period ended 30 April 2022, an expense of £5,000 and a
write back of prior year accruals of £7,000 (six months ended 30 April 2021:
expense of £5,000; year ended 31 October 2021: expense of £13,000) was credited
to the capital account of the Statement of Comprehensive Income. This relates
to transaction costs charged by the custodian on sale and purchase trades.
4 Relates to prior year accruals for custody transaction charges written
back during the period.
The transaction costs incurred on the acquisition of investments amounted to £
26,000 for the six months ended 30 April 2022 (six months ended 30 April 2021:
£40,000; year ended 31 October 2021: £103,000). Costs relating to the disposal
of investments amounted to £8,000 for the six months ended 30 April 2022 (six
months ended 30 April 2021: £18,000; year ended 31 October 2021: £39,000). All
transaction costs have been included within capital reserves.
6. DIVIDS
On 11 May 2022, the Directors declared a second quarterly interim dividend of
2.00p per share. The dividend will be paid on 1 July 2022 to shareholders on
the Company's register on 20 May 2022. This dividend has not been accrued in
the financial statements for the six months ended 30 April 2022 as, under IAS,
interim dividends are not recognised until paid. Dividends are debited directly
to reserves.
Dividends paid on equity shares during the period were:
Six months
ended
30 April
2022
(unaudited)
£'000
Fourth interim dividend for the year ended 31 October 2021 of 2.00p per 1,605
ordinary share paid on 4 January 2022
First interim dividend for the year ended 31 October 2022 of 2.00p per 1,605
ordinary share paid on 29 April 2022
---------------
3,210
=========
Second interim dividend for the year ended 31 October 2022 of 2.00p per 1,605
ordinary share payable on 1 July 20221
---------------
4,815
=========
1 Based on 80,229,044 ordinary shares in issue on 19 May 2022 (the
ex-dividend date).
7. EARNINGS AND NET ASSET VALUE PER ORDINARY SHARE
Total revenue return, capital return and net asset value per share are shown
below and have been calculated using the following:
Six months Six months Year
ended ended ended
30 April 30 April 31 October
2022 2021 2021
(unaudited) (unaudited) (audited)
Net revenue profit attributable to ordinary shareholders (£ 1,463 2,042 3,248
'000)
Net capital profit attributable to ordinary shareholders (£ 8,433 33,019 41,486
'000)
--------------- --------------- ---------------
Total profit attributable to ordinary shareholders (£'000) 9,896 35,061 44,734
--------------- --------------- ---------------
Equity shareholders' funds (£'000) 172,021 158,870 165,334
========= ========= =========
The weighted average number of ordinary shares in issue 80,229,044 79,829,958 80,031,140
during the period on which the earnings per ordinary share
was calculated was:
The actual number of ordinary shares in issue at the period 80,229,044 80,229,044 80,229,044
end on which the net asset value per ordinary share was
calculated was:
Earnings per ordinary share
Revenue earnings per share (pence) - basic and diluted 1.82 2.56 4.06
Capital earnings per share (pence) - basic and diluted 10.51 41.36 51.84
--------------- --------------- ---------------
Total earnings per share (pence) - basic and diluted 12.33 43.92 55.90
========= ========= =========
There were no dilutive securities at the period end (six months ended 30 April
2021: nil; year ended 31 October 2021: nil).
As at As at As at
30 April 30 April 31
2022 2021 October
(unaudited) (unaudited) 2021
(audited)
Net asset value per ordinary share (pence) 214.41 198.02 206.08
Ordinary share price (pence) 210.00 198.00 198.25
========= ========= =========
8. CALLED UP SHARE CAPITAL
Ordinary
shares Treasury Total Nominal
in issue shares shares value
(unaudited) number number number £'000
Allotted, called up and fully paid share capital
comprised:
Ordinary shares of 1 pence each:
At 31 October 2021 80,229,044 20,132,261 100,361,305 1,004
--------------- --------------- --------------- ---------------
At 30 April 2022 80,229,044 20,132,261 100,361,305 1,004
========= ========= ========= =========
During the six months ended 30 April 2022, no ordinary shares were reissued
from treasury (six months ended 30 April 2021 and year ended 31 October 2021:
445,000 shares were reissued for a total consideration including costs of £
886,000).
During the six months ended 30 April 2022, no shares were bought back and
transferred into treasury (six months ended 30 April 2021 and year ended
31 October 2021: 190,000 shares were bought back and transferred into treasury
for a total consideration including costs of £295,000).
Since 30 April 2022 and up to the date of this report, no ordinary shares have
been reissued from treasury and no ordinary shares have been bought back and
transferred into treasury.
9. RESERVES
The share premium and capital redemption reserve are not distributable profits
under the Companies Act 2006. In accordance with ICAEW Technical Release 02/
17BL on Guidance on Realised and Distributable Profits under the Companies Act
2006, the special reserve and capital reserve may be used as distributable
profits for all purposes and, in particular, the repurchase by the Company of
its ordinary shares and for payments as dividends. In accordance with the
Company's Articles of Association, the special reserve, capital reserves and
the revenue reserve may be distributed by way of dividend. The capital reserve
arising on the revaluation of investments of £19,243,000 (30 April 2021: gain
of £18,671,000; year ended 31 October 2021: gain of £16,745,000) is subject to
fair value movements and may not be readily realisable at short notice, as such
it may not be entirely distributable. The investments are subject to financial
risks, as such capital reserves (arising on investments sold) and the revenue
reserve may not be entirely distributable if a loss occurred during the
realisation of these investments.
10. VALUATION OF FINANCIAL INSTRUMENTS
Market risk arising from price risk
Price risk is the risk that the fair value or future cash flows of a financial
instrument will fluctuate because of changes in market prices (other than those
arising from interest rate risk or currency risk), whether those changes are
caused by factors specific to the individual financial instrument or its
issuer, or factors affecting similar financial instruments traded in the
market. Local, regional or global events such as war, acts of terrorism, the
spread of infectious illness or other public health issue, recessions, climate
change or other events could have a significant impact on the Company and its
investments.
The infectious respiratory illness caused by a novel coronavirus known as
COVID-19 has had a profound impact on all aspects of society over the last two
years. While there is a growing consensus in developed economies that the worst
of the impact is now over, there is an expectation that travel restrictions,
enhanced health screenings at ports of entry and elsewhere, disruption of and
delays in healthcare service preparation and delivery, cancellations, supply
chain disruptions, and lower consumer demand will create ongoing challenges.
While widescale vaccination programmes are now in place in many countries and
are having a positive effect, the impact of COVID-19 continues to adversely
affect the economies of many nations across the globe and this impact may be
greater where vaccination rates are lower, such as in certain emerging markets.
Although it is difficult to make timing predictions, it is expected that the
economic effects of COVID-19 will continue to be felt for a period after the
virus itself has moved from being pandemic to endemic in nature, and this in
turn may continue to impact investments held by the Company.
Valuation of financial instruments
Financial assets and financial liabilities are either carried in the Statement
of Financial Position at their fair value (investments and derivatives) or at
an amount which is a reasonable approximation of fair value (due from brokers,
dividends and interest receivable, due to brokers, accruals, cash at bank and
bank overdrafts). IFRS 13 requires the Company to classify fair value
measurements using a fair value hierarchy that reflects the significance of
inputs used in making the measurements. The valuation techniques used by the
Company are explained in the accounting policies note 2(g) as set out on pages
83 and 84 of the Company's Annual Report and Financial Statements for the year
ended 31 October 2021.
Categorisation within the hierarchy has been determined on the basis of the
lowest level input that is significant to the fair value measurement of the
relevant asset.
The fair value hierarchy has the following levels:
Level 1 - Quoted market price for identical instruments in active markets
A financial instrument is regarded as quoted in an active market if quoted
prices are readily available from an exchange, dealer, broker, industry group,
pricing service or regulatory agency and those prices represent actual and
regularly occurring market transactions on an arm's length basis. The Company
does not adjust the quoted price for these instruments.
Level 2 - Valuation techniques using observable inputs
This category includes instruments valued using quoted prices for similar
instruments in markets that are considered less active, or other valuation
techniques where all significant inputs are directly or indirectly observable
from market data.
Valuation techniques used for non-standardised financial instruments such as
options, currency swaps and other over-the-counter derivatives include the use
of comparable recent arm's length transactions, reference to other instruments
that are substantially the same, discounted cash flow analysis, option pricing
models and other valuation techniques commonly used by market participants
making the maximum use of market inputs and relying as little as possible on
entity specific inputs.
Over-the-counter derivative option contracts have been classified as Level 2
investments as their valuation has been based on market observable inputs
represented by the underlying quoted securities to which these contracts expose
the Company.
Level 3 - Valuation techniques using significant unobservable inputs
This category includes all instruments where the valuation technique includes
inputs not based on market data and these inputs could have a significant
impact on the instrument's valuation.
This category also includes all instruments that are valued based on quoted
prices for similar instruments where significant entity determined adjustments
or assumptions are required to reflect differences between the instruments and
instruments for which there is no active market. The Investment Manager
considers observable data to be that market data that is readily available,
regularly distributed or updated, reliable and verifiable, not proprietary and
provided by independent sources that are actively involved in the relevant
market.
The level in the fair value hierarchy within which the fair value measurement
is categorised in its entirety is determined on the basis of the lowest level
input that is significant to the fair value measurement. If a fair value
measurement uses observable inputs that require significant adjustment based on
unobservable inputs, that measurement is a Level 3 measurement.
Assessing the significance of a particular input to the fair value measurement
in its entirety requires judgement, considering factors specific to the asset
or liability. The determination of what constitutes 'observable' inputs
requires significant judgement by the Investment Manager.
Fair values of financial assets and financial liabilities
For exchange listed equity investments the quoted price is the bid price.
Substantially all investments are valued based on unadjusted quoted market
prices. Where such quoted prices are readily available in an active market,
such prices are not required to be assessed or adjusted for any price related
risks, including climate risk, in accordance with the fair value related
requirements of the Company's financial reporting framework.
The table below sets out fair value measurements using the IFRS 13 fair value
hierarchy.
Level 1 Level 2 Level 3 Total
Financial assets at fair value through profit or £'000 £'000 £'000 £'000
loss at 30 April 2022 (unaudited)
Assets:
Equity investments 176,665 - - 176,665
--------------- --------------- --------------- ---------------
176,665 - - 176,665
========= ========= ========= =========
Level 1 Level 2 Level 3 Total
Financial assets/(liabilities) at fair value through £'000 £'000 £'000 £'000
profit or loss at 30 April 2021 (unaudited)
Assets:
Equity investments 148,432 - - 148,432
Liabilities:
Derivative financial instruments - written options - (885) - (885)
--------------- --------------- --------------- ---------------
148,432 (885) - 147,547
========= ========= ========= =========
Level 1 Level 2 Level 3 Total
Financial assets at fair value through profit or £'000 £'000 £'000 £'000
loss at 31 October 2021 (audited)
Assets:
Equity investments 164,971 - - 164,971
--------------- --------------- --------------- ---------------
164,971 - - 164,971
========= ========= ========= =========
There were no transfers between levels for financial assets and financial
liabilities during the period/year recorded at fair value as at 30 April 2022,
30 April 2021 and 31 October 2021. The Company did not hold any Level 3
securities throughout the financial period under review or as at 30 April 2022,
30 April 2021 and 31 October 2021.
11. RELATED PARTY DISCLOSURE
Directors' emoluments
The Board consists of five non-executive Directors, all of whom are considered
to be independent of the Manager by the Board. None of the Directors has a
service contract with the Company. The Chairman receives an annual fee of £
42,000, the Audit and Management Committee Chairman receives an annual fee of £
35,000 and each of the Directors receives an annual fee of £29,000. At 30 April
2022, an amount of £14,000 (six months ended 30 April 2021: £14,000; year ended
31 October 2021: £14,000) was outstanding in respect of Directors' fees.
At 30 April 2022, interests of the Directors in the ordinary shares of the
Company are as set out below:
Six months Six months Year
ended ended ended
30 April 30 April 31
2022 2021 October
(unaudited) (unaudited) 2021
(audited)
Simon Miller (Chairman) 38,094 38,094 38,094
Christopher Casey 19,047 19,047 19,047
Andrew Irvine1 n/a 38,094 38,094
Alice Ryder 9,047 9,047 9,047
Melanie Roberts - - -
David Barron2 - n/a n/a
========= ========= =========
1 Retired on 22 March 2022.
2 Appointed on 22 March 2022.
Since the period end and up to the date of this report there have been no
changes in Directors' holdings.
12. TRANSACTIONS WITH THE INVESTMENT MANAGER AND AIFM
BlackRock Fund Managers Limited (BFM) provides management and administration
services to the Company under a contract which is terminable on six months'
notice. BFM has (with the Company's consent) delegated certain portfolio and
risk management services, and other ancillary services, to BlackRock Investment
Management (UK) Limited (BIM (UK)). Further details of the investment
management contract are disclosed on pages 46 and 47 of the Directors' Report
in the Company's Annual Report and Financial Statements for the year ended
31 October 2021.
The investment management fee due for the six months ended 30 April 2022
amounted to £592,000 (six months ended 30 April 2021: £552,000; year ended
31 October 2021: £1,137,000). At the period end £1,177,000 was outstanding in
respect of the investment management fee (six months ended 30 April 2021: £
528,000; year ended 31 October 2021: £876,000).
In addition to the above services, BlackRock has provided the Company with
marketing services. The total fees paid or payable for these services to 30
April 2022 amounted to £17,000 excluding VAT (six months ended 30 April 2021: £
18,000; year ended 31 October 2021: £37,000). Marketing fees of £46,000
excluding VAT (30 April 2021: £50,000; 31 October 2021: £29,000) were
outstanding as at 30 April 2022.
The ultimate holding company of the Manager and the Investment Manager is
BlackRock, Inc., a company incorporated in Delaware, USA.
13. CONTINGENT LIABILITIES
There were no contingent liabilities at 30 April 2022 (six months ended 30
April 2021: nil; year ended 31 October 2021: nil).
14. PUBLICATION OF NON STATUTORY ACCOUNTS
The financial information contained in this half yearly financial report does
not constitute statutory accounts as defined in Section 435 of the Companies
Act 2006. The financial information for the six months ended 30 April 2022 and
30 April 2021 has not been audited.
The information for the year ended 31 October 2021 has been extracted from the
latest published audited financial statements which have been filed with the
Registrar of Companies. The report of the auditors on those financial
statements contained no qualifications or statement under Sections 498(2) or
498(3) of the Companies Act 2006.
15. ANNUAL RESULTS
The Board expects to announce the annual results for the year ending 31 October
2022 in early February 2023.
Copies of the annual results announcement can be obtained from the Secretary on
0207 743 3000 or cosec@blackrock.com. The Annual Report and Financial
Statements should be available by the beginning of February 2023 with the
Annual General Meeting being held in March 2023.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Melissa Gallagher, Managing Director, Investment Trusts, BlackRock Investment
Management (UK) Limited - Tel: 020 7743 3000
Press enquiries:
Lansons Communications - Tel: 020 7294 3689
E-mail: BlackRockInvestmentTrusts@lansons.com
29 June 2022
12 Throgmorton Avenue
London EC2N 2DL
END
END
(END) Dow Jones Newswires
June 29, 2022 11:52 ET (15:52 GMT)
Blackrock Sustainable Am... (LSE:BRSA)
Historical Stock Chart
From Apr 2024 to May 2024
Blackrock Sustainable Am... (LSE:BRSA)
Historical Stock Chart
From May 2023 to May 2024